Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Rheumatic Diseases Clinics of North America
|
November 1, 1996
Cardiac involvement in scleroderma
A Deswal, W P Follansbee
Controlled Clinical Trials
|
December 12, 2001
Trials within trials: confirmatory subgroup analyses in controlled clinical experiments
L A Moyé, A Deswal
Heart Failure Reviews
|
April 20, 2001
The role of anti-cytokine therapy in the failing heart
A Deswal, A Misra, B Bozkurt
Current Opinion in Cardiology
|
June 8, 1999
An overview of tumor necrosis factor alpha and the failing human heart
G Torre-Amione, B Bozkurt, A Deswal, et al.
Heart Failure Monitor
|
March 14, 2003
Experimental options in the treatment of heart failure: the role of cytokine antagonism
D Kalra, B Bozkurt, A Deswal, et al.
The Journal of the Association of Physicians of India
|
April 1, 1988
Ranitidine and acute intermittent porphyria
D P Bhadoria, A K Srivastava, M Sharma, et al.
Alimentary Pharmacology & Therapeutics
|
April 4, 2007
Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident
N S Abraham, H B El-Serag, C Hartman, et al.
Chest
|
August 15, 2001
Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure: a report from the Vesnarinone Trial
A Deswal, N J Petersen, A M Feldman, et al.
The Journal of the Association of Physicians of India
|
November 1, 1988
Safe use of clonidine, nifedipine and vitamin K in hepatic porphyria
D P Bhadoria, A K Srivastava, M Sharma, et al.
Circulation
|
June 29, 1999
Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure
A Deswal, B Bozkurt, Y Seta, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Rheumatic Diseases Clinics of North America
|
November 1, 1996
Cardiac involvement in scleroderma
A Deswal, W P Follansbee
Controlled Clinical Trials
|
December 12, 2001
Trials within trials: confirmatory subgroup analyses in controlled clinical experiments
L A Moyé, A Deswal
Heart Failure Reviews
|
April 20, 2001
The role of anti-cytokine therapy in the failing heart
A Deswal, A Misra, B Bozkurt
Current Opinion in Cardiology
|
June 8, 1999
An overview of tumor necrosis factor alpha and the failing human heart
G Torre-Amione, B Bozkurt, A Deswal, et al.
Heart Failure Monitor
|
March 14, 2003
Experimental options in the treatment of heart failure: the role of cytokine antagonism
D Kalra, B Bozkurt, A Deswal, et al.
The Journal of the Association of Physicians of India
|
April 1, 1988
Ranitidine and acute intermittent porphyria
D P Bhadoria, A K Srivastava, M Sharma, et al.
Alimentary Pharmacology & Therapeutics
|
April 4, 2007
Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident
N S Abraham, H B El-Serag, C Hartman, et al.
Chest
|
August 15, 2001
Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure: a report from the Vesnarinone Trial
A Deswal, N J Petersen, A M Feldman, et al.
The Journal of the Association of Physicians of India
|
November 1, 1988
Safe use of clonidine, nifedipine and vitamin K in hepatic porphyria
D P Bhadoria, A K Srivastava, M Sharma, et al.
Circulation
|
June 29, 1999
Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure
A Deswal, B Bozkurt, Y Seta, et al.
Page
of 2